Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-025500

Director sold 1,570 shares at an average $30.00 ($47,104)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Heyman Richard A. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-10-18 Sale : show line 1 in the form 10b5-1 −817 $30.00 $24,512 123,673 D
2024-10-18 Sale : show line 2 in the form 10b5-1 −753 $30.00 $22,592 27,165 I
Open-market sales · 1,570 sh · avg $30.00 · $47,104
Loading xslF345X05/form4-10222024_081053.xml…